loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Telmisartan to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 150Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Gangwal Healthcare

02 2Aeon Procare

03 11BASF

04 2Ideal Cures Pvt Ltd

05 14Kerry

06 1Kima Chemical

07 1Lonza Capsugel

08 1Sigachi Industries

09 2The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

04

arrow
PPS Boston
Not Confirmed
arrow
PPS Boston
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

05

arrow
PPS Boston
Not Confirmed

07

arrow
PPS Boston
Not Confirmed

11

arrow
PPS Boston
Not Confirmed
arrow
PPS Boston
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

17

arrow
PPS Boston
Not Confirmed
arrow
PPS Boston
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank